Icahn School of Medicine at Mount Sinai shared a post on LinkedIn:
“We are proud to mark the 10-year anniversary of the International School of Immunotherapy (Immunoschool), a virtual global education initiative founded by Miriam Merad. What began as a three-country pilot in partnership with leading immunologists from Sorbonne Université and the USP – University of São Paulo has expanded to reach more than 2,000 learners across 82 countries.
The Immunoschool’s mission is to equip clinicians and basic scientists with the knowledge to harness the immune system for effective disease prevention and treatment.
Learn how this unique program is shaping the future of immunotherapy and training the next generation of scientific leaders.”
Bernard A. Fox, Co-founder, President, and CEO of UbiVac, shared this post, adding:
“Congrats to Miriam Merad, and Icahn School of Medicine at Mount Sinai on a decade of educational activities that democratize the science of immunotherapy.
The world is a better place because of your efforts.”
More posts featuring Icahn School of Medicine at Mount Sinai.